Table 2.
Adverse events
| Adverse events | Any grade | Grade 3-4 |
|---|---|---|
| Any | 28 (93.3) | 8 (26.7) |
| Hematologic, n (%) | ||
| Neutropenia | 2 (6.7) | 1 (3.3) |
| Anemia | 4 (13.3) | 2 (6.7) |
| Thrombocytopenia | 4 (13.3) | 3 (10.0) |
| Febrile neutropenia | 0 (0.0) | 0 (0.0) |
| Non-hematologic, n (%) | ||
| Anorexia | 4 (13.3) | 0 (0.0) |
| Nausea | 9 (30.0) | 2 (6.7) |
| Constipation | 7 (23.3) | 0 (0.0) |
| Diarrhea | 3 (10.0) | 0 (0.0) |
| Gastrointestinal hemorrhage | 1 (3.3) | 1 (3.3) |
| Fatigue | 6 (20.0) | 0 (0.0) |
| Fever | 3 (10.0) | 1 (3.3) |
| Hand-foot syndrome | 5 (16.7) | 0 (0.0) |
| Mucositis | 1 (3.3) | 0 (0.0) |
| Increased AST | 5 (16.7) | 1 (3.3) |
| Increased ALT | 4 (13.3) | 1 (3.3) |
| Increased ALP | 1 (3.3) | 0 (0.0) |
| Increased bilirubin | 2 (6.7) | 0 (0.0) |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.